+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vical Inc - logo

Vical Incorporated is a biopharmaceutical company that develops products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Its product candidates include CyMVectin prophylactic vaccine for cytomegalovirus (CMV), a therapeutic vaccine and prophylactic for herpes simplex virus type 2 and VL-2397 antifungal. The company was founded in 1987 and is headquartered in San Diego, California.

Global Therapeutic Vaccines Market Distribution by Type of Vaccine, Method of Vaccine Composition, Type of Therapy, Target Disease Indication, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Global Therapeutic Vaccines Market Distribution by Type of Vaccine, Method of Vaccine Composition, Type of Therapy, Target Disease Indication, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • May 2022
  • 365 Pages
From
Global Infectious Vaccines Partnering Terms and Agreements 2015 to 2022: Deal Trends, Players and Financials - Product Thumbnail Image

Global Infectious Vaccines Partnering Terms and Agreements 2015 to 2022: Deal Trends, Players and Financials

  • Report
  • May 2022
  • 450 Pages
From
Herpes Simplex - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Herpes Simplex - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
From
Therapeutic Vaccines - Global Market Trajectory & Analytics - Product Thumbnail Image

Therapeutic Vaccines - Global Market Trajectory & Analytics

  • Report
  • April 2021
  • 139 Pages
From
Global Subunit Vaccine Market 2022-2028 - Product Thumbnail Image

Global Subunit Vaccine Market 2022-2028

  • Report
  • April 2022
  • 120 Pages
From
Global DNA Vaccines Market 2019-2027 - Product Thumbnail Image

Global DNA Vaccines Market 2019-2027

  • Report
  • August 2019
  • 172 Pages
From
Middle East and Africa DNA Vaccines Market 2019-2027 - Product Thumbnail Image

Middle East and Africa DNA Vaccines Market 2019-2027

  • Report
  • August 2019
  • 72 Pages
From
Latin America DNA Vaccines Market 2019-2027 - Product Thumbnail Image

Latin America DNA Vaccines Market 2019-2027

  • Report
  • August 2019
  • 73 Pages
From
North America DNA Vaccines Market 2019-2027 - Product Thumbnail Image

North America DNA Vaccines Market 2019-2027

  • Report
  • August 2019
  • 88 Pages
From
Europe DNA Vaccines Market 2019-2027 - Product Thumbnail Image

Europe DNA Vaccines Market 2019-2027

  • Report
  • August 2019
  • 83 Pages
From
Asia-Pacific DNA Vaccines Market 2019-2027 - Product Thumbnail Image

Asia-Pacific DNA Vaccines Market 2019-2027

  • Report
  • August 2019
  • 88 Pages
From
US DNA Vaccine Market 2019-2025 - Product Thumbnail Image

US DNA Vaccine Market 2019-2025

  • Report
  • February 2020
From
North American DNA Vaccine Market 2019-2025 - Product Thumbnail Image

North American DNA Vaccine Market 2019-2025

  • Report
  • February 2020
From
Aspergillosis Drug Pipeline Report 2020 - Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs - Product Thumbnail Image

Aspergillosis Drug Pipeline Report 2020 - Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

  • Drug Pipelines
  • October 2019
  • 80 Pages
From
Antifungal Drugs Market Size, Share & Trends Analysis Report By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis), and Segment Forecasts, 2018 - 2025 - Product Thumbnail Image

Antifungal Drugs Market Size, Share & Trends Analysis Report By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis), and Segment Forecasts, 2018 - 2025

  • Report
  • December 2018
  • 100 Pages
From
Dengue DNA vaccine - Product Thumbnail Image

Dengue DNA vaccine

  • Drug Pipelines
  • January 2018
  • 10 Pages
From
2019 Cytomegalovirus (HHV-5) Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Cytomegalovirus (HHV-5) Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 118 Pages
From
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 to 2022 - Product Thumbnail Image

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 to 2022

  • Report
  • April 2022
  • 550 Pages
From
Global DNA Vaccine Market Research and Forecast, 2018-2023 - Product Thumbnail Image

Global DNA Vaccine Market Research and Forecast, 2018-2023

  • Report
  • April 2018
From
Metastatic Melanoma Therapeutics Market, by Therapy, by Stages, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 - Product Thumbnail Image

Metastatic Melanoma Therapeutics Market, by Therapy, by Stages, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • Report
  • August 2021
  • 168 Pages
From
Loading Indicator